| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $26.0M | +30.2% | +156.8% |
| Cost of Revenue | $24.4M | +2.2% | +69.2% |
| Gross Profit | $1.6M | +140.7% | +137.0% |
| R&D Expense | $1.2M | +8.8% | -16.3% |
| SG&A Expense | $6.4M | +24.0% | -5.9% |
| Operating Income | -$7.7M | +33.0% | +48.6% |
| Interest Expense | $2.0M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $24.4M | +592.5% | +195.2% |
| Accounts Receivable | $49.2M | +7.8% | +31.7% |
| Inventory | $7.7M | +4.6% | -49.4% |
| Current Assets | $96.6M | +37.4% | +26.7% |
| Total Assets | $111.5M | +34.4% | +21.6% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$25.4M | — | — |
| Capital Expenditures | $442K | +138.9% | +97.3% |
| Investing Cash Flow | $2.6M | — | — |
| Financing Cash Flow | $35.9M | — | — |
| Free Cash Flow | -$25.9M | — | — |
| +172.0% |
| — |
| Pre-tax Income | -$23.9M | -55.2% | -58.1% |
| Income Tax | $44K | +12.8% | -82.0% |
| Net Income | -$23.9M | -55.1% | -55.9% |
| EPS (Basic) | -$1.61 | -36.4% | -1241.7% |
| EPS (Diluted) | -$1.61 | -36.4% | -1241.7% |
| $58.1M |
| -4.1% |
| +1.4% |
| Long-term Debt | $16.6M | +52.8% | — |
| Total Liabilities | $125.3M | +69.5% | +104.4% |
| Stockholders' Equity | -$13.7M | -251.9% | -145.2% |